These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7438037)

  • 1. In vitro release of biologically active adriamycin by magnetically responsive albumin microspheres.
    Widder KJ; Senyei AE; Ranney DF
    Cancer Res; 1980 Oct; 40(10):3512-7. PubMed ID: 7438037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factorial design based optimization of the formulation of albumin microspheres containing adriamycin.
    Gupta PK; Hung CT; Lam FC
    J Microencapsul; 1989; 6(2):147-60. PubMed ID: 2723957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro release of adriamycin from drug-loaded albumin and haemoglobin microspheres.
    Willmott N; Cummings J; Florence AT
    J Microencapsul; 1985; 2(4):293-304. PubMed ID: 3939779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clarithromycin targeting to lung: optimization of the size, morphology and release characteristics of albumin microspheres.
    Ozkan Y; Dikmen N; Işimer A
    Acta Pol Pharm; 2000; 57(5):375-80. PubMed ID: 11126029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface-mediated cytotoxicity of polymer-bound Adriamycin against drug-resistant hepatocytes.
    Rogers KE; Carr BI; Tökés ZA
    Cancer Res; 1983 Jun; 43(6):2741-8. PubMed ID: 6850589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled release of bioactive doxorubicin from microspheres embedded within gelatin scaffolds.
    Defail AJ; Edington HD; Matthews S; Lee WC; Marra KG
    J Biomed Mater Res A; 2006 Dec; 79(4):954-62. PubMed ID: 16941588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of magnetically responsive albumin microspheres containing cis-hydroxyproline for scar inhibition.
    Iannotti JP; Baradet TC; Tobin M; Alavi A; Staum M
    J Orthop Res; 1991 May; 9(3):432-44. PubMed ID: 2010848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of drug delivery following the administration of magnetic albumin microspheres containing adriamycin to the rat.
    Gallo JM; Gupta PK; Hung CT; Perrier DG
    J Pharm Sci; 1989 Mar; 78(3):190-4. PubMed ID: 2724075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The cytotoxic effects of the adriamycin magnetic albumin microspheres combined with external magnetic fields on the malignant tumor cells].
    Tao K; Chen D; Tian Y; Wu Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2001 Jun; 18(2):223-6. PubMed ID: 11450539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary study on preparation and pharmaceutic features of adrimycin-loaded human serum albumin microspheres].
    Liu XB; Cai MY; Gong Y; Zhang ZR; Wei DP; Wang X; Li G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):107-9, 137. PubMed ID: 14981831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of targeted isoniazid microspheres.
    Bosela AA; el-Sayed MM; Mahmoud MI
    Boll Chim Farm; 1998 Mar; 137(3):77-81. PubMed ID: 9611845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres.
    Zolnik BS; Burgess DJ
    J Control Release; 2008 Apr; 127(2):137-45. PubMed ID: 18282629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxprenolol-loaded bioadhesive microspheres: preparation and in vitro/in vivo characterization.
    Preda M; Leucuta SE
    J Microencapsul; 2003; 20(6):777-89. PubMed ID: 14594666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug targeting: magnetically responsive albumin microspheres--a review of the system to date.
    Senyei AE; Widder KJ
    Gynecol Oncol; 1981 Aug; 12(1):1-13. PubMed ID: 7024051
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro study of GDNF release from biodegradable PLGA microspheres.
    Aubert-Pouëssel A; Venier-Julienne MC; Clavreul A; Sergent M; Jollivet C; Montero-Menei CN; Garcion E; Bibby DC; Menei P; Benoit JP
    J Control Release; 2004 Mar; 95(3):463-75. PubMed ID: 15023458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic characterization of 14C-vascular endothelial growth factor controlled release microspheres using a rat model.
    Kim TK; Burgess DJ
    J Pharm Pharmacol; 2002 Jul; 54(7):897-905. PubMed ID: 12162707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experiment and clinical application of targeting treatment with adriamycin magnetic albumin microspheres in human gastric carcinoma].
    Tao K; Chen D; Wang G; Bai Z; Lu X; Tian Y; Wu Z; Hu F; Nie X
    Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):205-7. PubMed ID: 11829819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel pH-dependent gradient-release delivery system for nitrendipine: I. Manufacturing, evaluation in vitro and bioavailability in healthy dogs.
    Yang M; Cui F; You B; You J; Wang L; Zhang L; Kawashima Y
    J Control Release; 2004 Aug; 98(2):219-29. PubMed ID: 15262414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytarabine release from comatrices of albumin microspheres in a poly(lactide-co-glycolide) film: in vitro and in vivo studies.
    Gómez C; Blanco MD; Bernardo MV; Olmo R; Muñiz E; Teijón JM
    Eur J Pharm Biopharm; 2004 Mar; 57(2):225-33. PubMed ID: 15018979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and preparation of controlled release lipid micropheres of sulphamethizole by a congealable disperse phase encapsulation method.
    Yüksel N; Aydmli A; Ozalp Y; Ozdemir N
    Acta Pol Pharm; 2000; 57(3):187-92. PubMed ID: 11143707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.